Interpretation of WHO global tuberculosis report 2023

doi:10.19983/j.issn.2096-8493.2024006

Journal of Tuberculosis and Lung Disease ›› 2024, Vol. 5 ›› Issue (1): 15-19.doi: 10.19983/j.issn.2096-8493.2024006

• Interpretation of Standards • Previous Articles Next Articles

Interpretation of WHO global tuberculosis report 2023

hu Wei, Liu Yuhong()

Beijing Chest Hospital, Capital Medical University/Clinical Center on Tuberculosis, China CDC/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China

Received:2023-12-03 Online:2024-02-20 Published:2024-02-02
Contact: Liu Yuhong E-mail:liuyuhong0516@126.com
Supported by:
Beijing Municipal Health Commission High Level Public Health Talent Construction Project(Discipline Leader 01-11)

Abstract

Abstract:

In November 2023, the World Health Organization published the Global tuberculosis report 2023, which focuses on the updated global burden of the tuberculosis epidemic, notifications, treatment outcomes, innovation, and development. The authors interpret the burden of global tuberculosis, status of diagnosis and treatment s of the Global Report and provides a reference for peers to comprehensively understand global strategies, actions, and progress on tuberculosis prevention and control.

Key words: Tuberculosis, Research, Consensus development conference

CLC Number:

hu Wei, Liu Yuhong. Interpretation of WHO global tuberculosis report 2023[J]. Journal of Tuberculosis and Lung Disease , 2024, 5(1): 15-19. doi: 10.19983/j.issn.2096-8493.2024006

References 6

[1]	World Health Organization. Global tuberculosis report 2023. Geneva: World Health Organization, 2023.
[2]	General Assembly of the United Nations. Political Declaration of the High-Level Meeting on the Fight against Tuberculosis:draft resolution/submitted by the President of the General Assembly. New York: General Assembly of the United Nations, 2023.
[3]	World Health Organization. Use of targeted next-generation sequencing to detect drug-resistant tuberculosis Rapid communication, 2023.Geneva: Word Health Organization, 2023.
[4]	黄海荣. 世界卫生组织《应用新一代靶向测序技术检测耐药结核病:快速通告,2023》解读中国防痨杂志, 2023, 45(10): 921-492.:doi:10.19982/j.issn.1000-6621.20230311.
[5]	World Health Organization. Use of bedaquiline in children and adolescents with multidrug- and rifampicin-resistant tuberculosis: information note. 2023 Geneva: Word Health Organization, 2023.
[6]	张立杰, 刘宇红. 联合国大会第二届《结核病防治高级别会议政治宣言》解读. 中国防痨杂志, 2023, 45(12): 1117-1119. doi:10.19982/j.issn.1000-6621.20230380.

[1]	National Center of Medical Quality Control for Respiratory Diseases , Tuberculosis Branch of Chinese Medical Association , Tuberculosis Control Branch of Chinese Antituberculosis Association , China⁃Japan Friendship Hospital . Clinical practice guidelines for early detection of pulmonary tuberculosis in general medical facilities [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 1-14.
[2]	Ni Nan, Chen Qing, Tang Xianzhen, Zou Liping, Liang Li, Wu Guihui, Mao Li. Analysis of drug resistance status and influencing factors in 203 aged patients with pulmonary tuberculosis combined with type 2 diabetes [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 28-36.
[3]	Yao Xiaowei, Liu Shuren, Jing Yanse, Jia Chenguang. Evaluation of next generation sequencing for the diagnosis of osteoarticular tuberculosis infection [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 37-43.
[4]	Xue Jianhang, Cao hong, Li Lu, Liu Xunrui, Ma Guilin, Zheng Rongrong, Ke Ran. Analysis of treatment outcome and influencing factors of 308 patients with multidrug-resistant pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 44-50.
[5]	Niu Peixuan, A Ertai, Li Yuanyuan, Guan Wenlong, Zheng Tian, Su Dongdong, Du Qingqing, Du Caiyun. Epidemiological characteristics analysis of hospitalized patients with extrapulmonary tuberculosis in Xinjiang Uygur Autonomous Region from 2018 to 2022 [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 51-57.
[6]	Yang Chao, Wang Jing, Tang Guilin, Gao Hanqing, Wang Bin. Analysis of patient delay and its influencing factors among elderly pulmonary tuberculosis patients in Tongzhou District of Beijing, 2016—2022 [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 58-63.
[7]	Zhang Taifa, Zhou Hua. Epidemiological characteristics of pulmonary tuberculosis in Taicang City from 2017 to 2022 [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 64-69.
[8]	Liang Chen, Tang Shenjie, Lin Minggui. Research progress of comprehensive treatment for tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 70-80.
[9]	Cao Hong, Qian Bing, Wu Jinju. Current situation of tuberculosis epidemic in schools and research progress in prevention and control [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 88-92.
[10]	Cao Yuqing, Shang Xiyu, Xiong Yibai, Ji Xinyu, Ma Yan. Revelation and reference from successful experience of artemisinin to tuberculosis prevention and control [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(6): 442-448.
[11]	Xu Yujing, Li Yuru, Tang Lingling. Evaluation of the application effect of diversified missionary nursing on multidrug-resistant pulmonary tuberculosis patients [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(6): 449-453.
[12]	Wang Danfeng, Du Guichun. Evaluation of focused nursing care on treatment compliance and prognosis of drug-resistant pulmonary tuberculosis patients [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(6): 454-456.
[13]	Weng Jianfeng, Chen Wenjie, Liu Zhidong, Chen Hao, Li Xiaofen, Yin Qingqing, Yao Zhuocheng. Analysis of the status and influencing factors of tuberculosis management system based on mobile Wechat [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(6): 457-462.
[14]	Tang Yuhong, Qin Yi, Yi Benju, Xiang Yang. Analysis of factors influencing latent tuberculosis infection among high school sophomores [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(6): 463-467.
[15]	Weng Jianfeng, Chen Wenjie, Liu Zhidong, Chen Hao, Li Xiaofen, Yin Qingqing, Yao Zhuocheng. Evaluation of implementation effect of management model of WeChat APP based tuberculosis management system in Huizhou [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(6): 468-474.

Interpretation of WHO global tuberculosis report 2023

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 6

Related Articles 15

Recommended Articles

Metrics

Comments